Legal Updates
7 min read
Camp Lejeune: DOJ Cites Tylenol Expert Ruling
Aug. 13 report: DOJ asked EDNC judges to apply a July 13 Tylenol expert ruling. Same filing cites 3,773 suits, 408,000+ claims, and an 88% proof gap.
Read
#litigation update
11 articles with this tag
Legal Updates
8 min read
Legal Updates
8 min read
Social Media MDL Hits 2,893 Cases in July 2026
MDL-3047 reached 2,893 pending cases as Breathitt County's ~$27M school settlement and a July 27 California bellwether reshape social media addiction litigation.
Read
Legal Updates
7 min read
Camp Lejeune: Court Sets Oct 30 Settlement Deadline
EDNC judges ordered DOJ and plaintiff leadership to reach a Camp Lejeune global settlement framework by October 30, 2026, or face restructuring.
Read
Legal Updates
7 min read
Covidien Mesh: First Bellwether Starts July 2026
The first Covidien hernia mesh bellwether trial opened July 13, 2026 in D. Mass. with 2,400+ cases pending in MDL 3029.
Read
Mass Tort News
7 min read
Hair Relaxer MDL Hits 11,877 Cases as Judge Takes Over Bellwethers
The hair relaxer MDL reached 11,877 cases on July 1 (the fourth-largest MDL) after Judge Rowland took direct control of bellwether selection. Motions due Nov 16.
Read
Mass Tort News
8 min read
Mass Tort News
7 min read
Video Game Addiction Suits Top 100 as California Rulings Loom
100+ video game addiction cases are coordinated in California's JCCP 5363, with arbitration and dismissal rulings expected after the JPML denied a national MDL.
Read
Mass Tort News
7 min read
Bard PowerPort MDL: Fracture Case Heads to Trial August 18
Following a split first verdict, the second Bard PowerPort bellwether (a catheter fracture case) goes to trial August 18, 2026, with 3,376 cases pending.
Read
Mass Tort News
7 min read
Depo-Provera Settlement: Pfizer Reaches Global Deal in MDL 3140
Pfizer reached a global settlement in principle in the Depo-Provera MDL on June 15, 2026, after a record 1,739 filings in June pushed the docket past 5,500 cases.
Read
Mass Tort News
7 min read
Depo-Provera Litigation: FDA Warning Reshapes MDL as Cases Surpass 2,100
FDA adds meningioma warning to Depo-Provera label as MDL 3140 surpasses 2,100 cases. First bellwether trial set for December 2026.
Read